Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 75

Sort by

Sort Order Select

Journal Articles

The mTOR Component, Rictor, Is Regulated By the Microenvironment to Control Dormancy and Proliferative States in Myeloma Cells

Syed J. Mehdi, PhD, Sarah K Johnson, PhD, Tarun K. Garg, PhD, Cody Ashby, PhD, Maurizio Zangari, MD, Carolina D. Schinke, MD, Sharmilan Thanendrarajan, MD, Joshua Epstein, DSc, Brian A Walker, PhD, Frits van Rhee, MD PhD, Shmuel Yaccoby, PhD

Blood (2019) 134 (Supplement_1): 4412.

https://doi.org/10.1182/blood-2019-127382

Published: 2019

Journal Articles

Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen

Patrick Hagen, MD, Anita D'Souza, MDMS, Parameswaran Hari, MBBS, MD, Omar Davila, Mei-Jie Zhang, David H. Vesole, MD PhD, Scott E. Smith, MD PhD, Tulio E Rodriguez, MD, Patrick J. Stiff, MD

Blood (2019) 134 (Supplement_1): 2023.

https://doi.org/10.1182/blood-2019-124188

Published: 2019

Journal Articles

Comparative Inflammasome Analysis of Bone Marrow Stroma in Aging and Myelofibrosis

Larissa Balaian, PhD, Leslie A Crews, PhD, Cayla Mayson, BS, Frida Holm, PhD, Raymond H Diep, Heather Leu, BS, Anna Kulidjian, MD, Edward D. Ball, MD, Catriona Jamieson, MD PhD

Blood (2018) 132 (Supplement 1): 4331.

https://doi.org/10.1182/blood-2018-99-118993

Published: 2018

Journal Articles

An Analysis of Early Toxicities, Associated Risk Factors and Survival during the First Year in Adults Undergoing Ex-Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Michael Scordo, MD, Gunjan Shah, MD M.S., Molly A. Maloy, MS, Sean Devlin, PhD, Jimmy Nieves, RN, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Brian C. Shaffer, MD, Boglarka Gyurkocza, MD, Hugo R. Castro-Malaspina, MD, Roni Tamari, MD, Sergio A. Giralt, MD, Miguel Perales, MD

Blood (2016) 128 (22): 2194.

https://doi.org/10.1182/blood.V128.22.2194.2194

Published: 2016

Journal Articles

A Comprehensive Analysis of Late Toxicities and Associated Risk Factors in Long-Term Survivors of Myeloablative Conditioned Allogeneic Hematopoietic Cell Transplantation Using Ex-Vivo CD34+ Selection-Based Graft-Versus-Host Disease Prophylaxis

Michael Scordo, MD, Gunjan L. Shah, MDMS, Satyajit Kosuri, MD, Diego Adrianzen Herrera, MD, Sean Devlin, PhD, Molly A. Maloy, MS, Jimmy Nieves, RN, Taylor Borrill, CCRP, Scott T. Avecilla, MD PhD, Richard C. Meagher, PhD, Richard J. O'Reilly, MD, Guenther Koehne, MD PhD, Boglarka Gyurkocza, MD, Hugo Castro-Malaspina, MD, Roni Tamari, MD, Miguel Perales, MD, Sergio A. Giralt, MD, Brian C. Shaffer, MD

Blood (2016) 128 (22): 4621.

https://doi.org/10.1182/blood.V128.22.4621.4621

Published: 2016

Journal Articles

Periostin Supports Hematopoietic Stem/Progenitor Cells and Niche-Dependent Myeloblastoma Cells In Vitro

Akio Maekawa, Natsumi Hasegawa, Satowa Tanaka, Leo Matsubara, Azusa Imanishi, Masaya Yano, Robert Roeder, PhD, Shigetaka Asano, MD DMSci, Mitsuhiro Ito, MD PhD

Blood (2016) 128 (22): 1494.

https://doi.org/10.1182/blood.V128.22.1494.1494

Published: 2016

Journal Articles

CD34+ Selection Avoids Methotrexate and Reduces the Severity of Oral Mucositis in TBI-Based Allogeneic Stem Cell Transplantation

Ankit Anand, MD, Prathima Anandi, MD, Jain A. Natasha, MD, Kit Lu, MD, Neil Dunavin, MD, Christopher S. Hourigan, MDPhD, Robert Q. Le, MDPhD, Puja D. Chokshi, MD, Sawa Ito, MD, David F. Stroncek, MD, Marianna Sabatino, MD, John Barrett, MD, Minoo Battiwalla, MDMS

Blood (2014) 124 (21): 3898.

https://doi.org/10.1182/blood.V124.21.3898.3898

Published: 2014

Journal Articles

FGF7 Supports Hematopoietic Stem and Progenitor Cells and Niche-Dependent Myeloblastoma Cells Via Autocrine Action On Bone Marrow Stromal Cells In Vitro

Ruri Ishino, Keiji Matsui, Satowa Tanaka, Kaori Minami, Yukiko Ikeuchi, Masaya Yano, Azusa Imanishi, Mami Nagai, Natsumi Hasegawa, Shigetaka Asano, MD, DSci, Mitsuhiro Ito, MD, PhD

Blood (2013) 122 (21): 3684.

https://doi.org/10.1182/blood.V122.21.3684.3684

Published: 2013

Journal Articles

High Dose Intravenous Busulfan and Melphalan Followed By Bortezomib (BuMelVel) As Conditioning With Autologous Stem Cell Transplantation (ASCT) For Patients With Multiple Myeloma (MM)

Danielle Sterrenberg, MD, Patrick J Stiff, MD, Mala Parthasarathy, MS, Aileen Go, MD, Scott E. Smith, MD, PhD, Tulio E. Rodriguez, MD

Blood (2013) 122 (21): 3376.

https://doi.org/10.1182/blood.V122.21.3376.3376

Published: 2013

Journal Articles

Palifermin For Prevention Of Oral Mucositis Has No Negative Effect On Long-Term Outcome In Patients With Hematological Malignancies Undergoing HSCT - Long-Term Follow-Up To 15 Years

Patrick J Stiff, MD, Ricardo Spielberger, MD

Blood (2013) 122 (21): 4631.

https://doi.org/10.1182/blood.V122.21.4631.4631

Published: 2013

Journal Articles

Compare The Outcome Of Patients With Hematological Malignancies Treated With Allogeneic Stem Cell Transplant In Patients Age Over 50 Conditioned With Reduce Intensity Regimens With Those Under 50 Conditioned With Standard Intensity Regimen In a Rural University Hospital – A Single Institution Experience

Luke N. D'Cunha, BS; BA, Nicholas C. D'Cunha, MD, Deanna Harville, BS, Everardo Cobos, MD

Blood (2013) 122 (21): 5549.

https://doi.org/10.1182/blood.V122.21.5549.5549

Published: 2013

Journal Articles

Neutralization Of Vascular Endothelial Growth Factor-A Induced CD138-Expression In Bone Marrow Cells From Multiple Myeloma Patients

Ryosuke Shirasaki, MD, PhD, Takuji Matsuo, MD, Yoko Oka, MD, PhD, Jun Ooi, MD, Naoki Shirafuji, MD,PhD

Blood (2013) 122 (21): 5331.

https://doi.org/10.1182/blood.V122.21.5331.5331

Published: 2013

Journal Articles

Poor Graft Function in Recipients of T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral Therapy.

Roni Tamari, MD, Sheetal Ramnath, Deborah Kuk, MS, Craig S. Sauter, MD, Doris M Ponce, MD, Sean Devlin, PhD, James W. Young, MD, Sergio Giralt, MD, Hugo R Castro-Malaspina, MD

Blood (2012) 120 (21): 3147.

https://doi.org/10.1182/blood.V120.21.3147.3147

Published: 2012

Journal Articles

A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Haematopoietic Stem Cell Transplantation

Atul Sharma, DM, Tilak Tvsvgk, Vinod Raina, Lalit Kumar, DM, Sameer Bakhshi, Surendra Pal Chaudhary, Ranjit Kumar Sahoo

Blood (2012) 120 (21): 4500.

https://doi.org/10.1182/blood.V120.21.4500.4500

Published: 2012

Journal Articles

A Phase II Trial of Peri-Transplant Palifermin with Busulfan, Melphalan and Fludarabine Followed by T-Cell Depleted Hematopoietic Stem Cell Transplants in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved From MDS

Roni Tamari, MD, Sheetal Ramnat Sheetal, Deborah Kuk, MS, Esperanza B. Papadopoulos, MD, Ann A. Jakubowski, MD, PhD, Farid Boulad, MD, Trudy N. Small, MD, Nancy A. Kernan, MD, Miguel A Perales, MD, Guenther Koehne, MD, PhD, Doris M Ponce, MD, Sean Devlin, PhD, Jenna D Goldberg, MD, James W. Young, MD, Sergio A Giralt, MD, Richard J. O'Reilly, MD, Hugo R Castro-Malaspina, MD

Blood (2012) 120 (21): 1935.

https://doi.org/10.1182/blood.V120.21.1935.1935

Published: 2012

Journal Articles

Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a

Beata Berent-Maoz, Encarnacion Montecino-Rodriguez, Robert A. J. Signer, Kenneth Dorshkind

Blood (2012) 119 (24): 5715–5721.

https://doi.org/10.1182/blood-2011-12-400002

Published: 2012

Includes: Supplemental data

Journal Articles

Cytokine/Chemokine Expression with Protein Arrays Identifies Three Subsets of T-Cell Lymphomas with Differented Immunological Profiles,

Santiago Mercadal, Sr., Antonio Martinez, Lluis Colomo, MD, PhD, Elias Campo, Armando Lopez-Guillermo, MD

Blood (2011) 118 (21): 3473.

https://doi.org/10.1182/blood.V118.21.3473.3473

Published: 2011

Journal Articles

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

Giuseppe Milone, MD, Massimo Poidomani, MD, Salvatore Leotta, MD, Valeria Pinto, MD, Andrea Spadaro, Rita Lombardo, MD, Giovanni Tripepi, MD

Blood (2011) 118 (21): 4568.

https://doi.org/10.1182/blood.V118.21.4568.4568

Published: 2011

Journal Articles

Randomized Controlled Trial of Two Different Dosing Regimens of Palifermin to Prevent Mucositis In Multiple Myeloma Patients Receiving One-Day Administration of High-Dose Melphalan

Nicole M.A. Blijlevens, MD, PhD, Maarten E de Chateau, MD, PhD, Gergely Krivan, MD, Werner Rabitsch, MD, Arpad Szomor, MD, Robert Pytlik, MD, Agneta Lissmats, PhD, Hans Erik Johnsen, MD, Tapani Ruutu, MD, Hermann Einsele, MD, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 904.

https://doi.org/10.1182/blood.V116.21.904.904

Published: 2010

Journal Articles

Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy

Despina Mallouri, Ioanna Sakellari, Ioannis Batsis, Varnavas Konstantinou, Panayotis Baliakas, Athanasios Antoniou, Chrisa Apostolou, Achilles Anagnostopoulos, Athanasios Fassas

Blood (2010) 116 (21): 1324.

https://doi.org/10.1182/blood.V116.21.1324.1324

Published: 2010

NARROW

The mTOR Component, Rictor, Is Regulated By the Microenvironment to Control Dormancy and Proliferative States in Myeloma Cells

Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Long Term Follow up of a Novel Conditioning Regimen

Comparative Inflammasome Analysis of Bone Marrow Stroma in Aging and Myelofibrosis

An Analysis of Early Toxicities, Associated Risk Factors and Survival during the First Year in Adults Undergoing Ex-Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

A Comprehensive Analysis of Late Toxicities and Associated Risk Factors in Long-Term Survivors of Myeloablative Conditioned Allogeneic Hematopoietic Cell Transplantation Using Ex-Vivo CD34+ Selection-Based Graft-Versus-Host Disease Prophylaxis

Periostin Supports Hematopoietic Stem/Progenitor Cells and Niche-Dependent Myeloblastoma Cells In Vitro

CD34+ Selection Avoids Methotrexate and Reduces the Severity of Oral Mucositis in TBI-Based Allogeneic Stem Cell Transplantation

FGF7 Supports Hematopoietic Stem and Progenitor Cells and Niche-Dependent Myeloblastoma Cells Via Autocrine Action On Bone Marrow Stromal Cells In Vitro

High Dose Intravenous Busulfan and Melphalan Followed By Bortezomib (BuMelVel) As Conditioning With Autologous Stem Cell Transplantation (ASCT) For Patients With Multiple Myeloma (MM)

Palifermin For Prevention Of Oral Mucositis Has No Negative Effect On Long-Term Outcome In Patients With Hematological Malignancies Undergoing HSCT - Long-Term Follow-Up To 15 Years

Neutralization Of Vascular Endothelial Growth Factor-A Induced CD138-Expression In Bone Marrow Cells From Multiple Myeloma Patients

Poor Graft Function in Recipients of T Cell Depleted (TCD) Allogeneic Hematopoietic Stem Cell Transplants (HSCT) Is Mostly Related to Viral Infections and Anti-Viral Therapy.

A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Haematopoietic Stem Cell Transplantation

A Phase II Trial of Peri-Transplant Palifermin with Busulfan, Melphalan and Fludarabine Followed by T-Cell Depleted Hematopoietic Stem Cell Transplants in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved From MDS

Fibroblast growth factor-7 partially reverses murine thymocyte progenitor aging by repression of Ink4a

Cytokine/Chemokine Expression with Protein Arrays Identifies Three Subsets of T-Cell Lymphomas with Differented Immunological Profiles,

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

Randomized Controlled Trial of Two Different Dosing Regimens of Palifermin to Prevent Mucositis In Multiple Myeloma Patients Receiving One-Day Administration of High-Dose Melphalan

Intravenous Busulphan in Combination with ETOPOSIDE and MELPHALAN Used as Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Lymphomas: Evaluation of Toxicity and Efficacy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only